4
Changes in Ownership
Pharvaris N.V. Filed Acc 0001193125-26-201906
Chief Medical Officer sold 18,733 shares at an average $30.21 ($565,859)
- Chief Medical Officer acquired 18,733 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lu Peng · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,733 | $2.59 | $9,668 | 69,816 | D |
| 2026-04-29 | Sale : show line 2 in the form 10b5-1 | −3,733 | $30.06 | $112,232 | 62,350 | D |
| 2026-04-30 | Exercise or conversion : show line 3 in the form 10b5-1 | +15,000 | $2.59 | $38,850 | 81,083 | D |
| 2026-04-30 | Sale : show line 4 in the form 10b5-1 | −15,000 | $30.24 | $453,627 | 66,083 | D |
| Open-market sales · 18,733 sh · avg $30.21 · $565,859 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-29 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −3,733 | 234,474 | D |
| 2026-04-30 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −15,000 | 219,474 | D |
Loading xslF345X06/ownership.xml…